MedPath

Time-restricted Eating and Interval Training With Digital Follow-up

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Behavioral: Time-restricted eating and high-intensity interval training
Registration Number
NCT05505305
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

This study will investigate the effects of seven weeks of time-restricted eating combined with high-intensity interval training compared with a control group on body composition in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive weekly follow-up through online platforms (telephone, video call). Before and after the intervention, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Body mass index ≥ 27 kg/m²
  • Able to walk or ride a bike > 60 min
Exclusion Criteria
  • On-going pregnancy
  • Lactation within 24 weeks of study commencement
  • High-intensity exercise ≥ 1/week
  • Habitual eating window ≤12 hours/day
  • Taking hypertension, glucose-, or lipid-lowering drugs
  • Body mass variation ≥ 4 kg three months prior to study commencement
  • Known diabetes mellitus (type 1 or 2) or cardiovascular disease
  • Working night shifts

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Time-restricted eating and high-intensity interval trainingTime-restricted eating and high-intensity interval trainingSeven weeks of time-restricted eating and high-intensity interval training with digital follow-up.
Primary Outcome Measures
NameTimeMethod
Total fat massFrom baseline to after 7 weeks of intervention

Change in total fat mass measured with bioelectrical impedance analysis

Secondary Outcome Measures
NameTimeMethod
InsulinFrom baseline to after 7 weeks of intervention

Fasting concentration of plasma insulin C-peptide

Systolic blood pressureFrom baseline to after 7 weeks of intervention

Average of three measurements during rest in seated position, in mmHg

Physical activity levelFrom baseline to after 7 weeks of intervention

International Physical Activity Questionnaire, categorical score

Average glucose levelsFrom baseline to after 7 weeks of intervention

Glycated hemoglobin (HbA1c)

Cardiorespiratory fitnessFrom baseline to after 7 weeks of intervention

Peak oxygen uptake at a maximum effort exercise test, measured in mL/min/kg and L/min

Visceral fat areaFrom baseline to after 7 weeks of intervention

In cm², estimated with bioelectrical impedance analysis

Sleep duration7 days at baseline, 7 days at start of intervention, 7 days at end of intervention

Self-reported hours of sleep per night during baseline week, first week of intervention, and last week of intervention, average hours/night

Blood glucoseFrom baseline to after 7 weeks of intervention

Fasting concentration of plasma glucose

Blood CholesterolFrom baseline to after 7 weeks of intervention

Total fasting cholesterol in blood

Insulin sensitivityFrom baseline to after 7 weeks of intervention

Homeostatic model assessment for insulin resistance (HOMA-IR): 1.5 + fasting plasma glucose (mmol/L) × fasting plasma insulin C-peptide (pmol/L) / 2800

HDL-cholesterol in bloodFrom baseline to after 7 weeks of intervention

Fasting high-density lipoprotein-cholesterol in blood

Triglycerides in bloodFrom baseline to after 7 weeks of intervention

Fasting triglycerides in blood

Body massFrom baseline to after 7 weeks of intervention

In kg, estimated with bioelectrical impedance analysis

LDL-cholesterol in bloodFrom baseline to after 7 weeks of intervention

Fasting low-density lipoprotein-cholesterol in blood

Body fat-free massFrom baseline to after 7 weeks of intervention

In kg, estimated with bioelectrical impedance analysis

Diastolic blood pressureFrom baseline to after 7 weeks of intervention

Average of three measurements during rest in seated position, in mmHg

Resting heart rateFrom baseline to after 7 weeks of intervention

Average of three measurements during rest in sitting position, in beats/min

Appetite7 days at baseline, 7 days at start of intervention, 7 days at end of intervention

Self-reported ratings of hunger/satiety on visual analogue scale upon waking and before bedtime during baseline week, first week of intervention, and last week of intervention, average hours/night

Self-reported physical activity7 days at baseline, 7 days at start of intervention, 7 days at end of intervention.

Self-reported duration and intensity of daily physical activity during baseline week, first week of intervention, and last week of intervention, in metabolic equivalent of task (MET)/week

Diet intake7 days at baseline, 7 days at start of intervention, 7 days at end of intervention.

Online food diary during baseline week, first week of intervention, and last week of intervention, in kilojoules (kJ)/week

Sleep qualityFrom baseline to after 7 weeks of intervention

The Pittsburgh Sleep Quality Index questionnaire

Trial Locations

Locations (1)

Department of circulation and medical imaging, NTNU

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath